Medicines continue to form the mainstay of treatment methods for most medical conditions known today, despite some speculations that chemicals in the human body may be self-regulated via nanobots in the future.
But that future is still 50 years away. At present, healthcare is still learning to cope with the possibilities of precision medicine and artificial intelligence.
The domestic pharmaceuticals market is said to be the world’s third largest in terms of volume and thirteenth largest by value. Implying that one out of every three tablets available anywhere in the world has been produced by an Indian company. The sector was valued at USD 33 billion in 2017; and by September 2018, the market had grown by 9.7% to tally almost USD 18 billion. The US makes up for 40% of all generic medicine demand from India, while its pharma workforce boasts of great representation in new drug applications and drug master files applications in the country. Healthcare has seen a clear shift toward patient centrality and quality enhancement while pharmaceuticals are moving towards niche products. There are several new areas, which modern pharma employees need to have knowledge of and train themselves to remain relevant and have a sustainable role in tomorrow’s industry.
Biosimilars and rare diseases
Denne historien er fra February 2019-utgaven av Pharma Bio World.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra February 2019-utgaven av Pharma Bio World.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
B&R Expands Gilgenberg Site
Automation specialist invests in production, office space and logisticsB&R is investing in its Gilgenberg site, located a few kilometers from the B&R headquarters in Eggelsberg. The expansion adds new offices, training rooms and production space. A new logistics hall has also been opened at the site.
Creating An Annual Event Of The Biopharma Industry By Focusing On Frontiers, & Promoting Leading Enterprises To Collaborate
The Union Budget 2018 was presented on February 1, 2018.
Pain Point To Gaining Brownie Points: Technology Is A Game Changer For Indian Pharma Sector
The Indian pharmaceutical industry has come a long way from traditional home-made herbal medicines to being the manufacturer of world class life-saving drugs. However, at the helm of game-changing innovations steering this industry to a whole new level is the implementation of technology.
Data Acquisition, Evaluation And Transmission To The Cloud
A single device to acquire data, evaluate it and send it to the cloud – that’s now possible with B&R’s Edge Controller. The powerful industrial PC can even be used for big data analysis and machine learning, while at the same time serving as a full-fledged industrial controller.
Just The Right Dose Of Intelligence
Nothing herein shall constitute an offer to sell, or a solicitation of an offer to buy. The ACOPO Strak product is not available for sale into the United States of America until September 2018.
Considerations For Extraction, Stabilization And Quantification By PCR For Sensitive Sample Such As RNA
This article talks about careful selection of an extraction system that helps stabilize and protect targets, especially RNA, or which allows for immediate analysis.
Novel Research In Pharmaceuticals And Bio-Pharmaceuticals
This article covers entire spectra of pharmaceutical research and as well as those related to synthesis and processing of pharmaceuticals.
Boost Productivity With Anti-sloshing
Transport liquids faster without spills With B&R’s industrial transport system, it is now possible to transport liquids quickly with no spills. SuperTrak is the only system on the market to offer anti-sloshing technology. This technology suppresses the format ion of oscillations on free surfaces to prevent liquids from spilling over container edges during transport .
Rational Use Of Drugs And Irrational Drug Combinations
Irrational use of medicines is a global phenomenon. Rational use of drugs may be defined as: Patients receive medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time, and the lowest cost to them and their community. Overuse, polypharmacy and incorrect use of drugs are the most common problems of drug use today. Irrational use of drugs may result due to various reasons at various levels including the prescribing errors and over the counter drugs. Irrational use of medicines may lead to serious negative health and economic consequences. Many irrational drug combinations are available in the Indian market. Proper implementation of rational use of drugs will improve the quality of life and result in better community healthcare.
Cold Chain Management For Sensitive Goods
Packaging, route planning and risk analysis ensure safe conditions during transportation of delicate drugs. Drugs are sensitive goods to transport, which can be subject to irreversible damage if they are stored or transported at temperatures outside the tolerated range. If the temperature falls below or rises above the specified range the quality of drugs requiring refrigeration can be seriously affected and they may cease to be effective. This article therefore describes how transport conditions during the transportation of drugs can be optimised through suitable packaging, individualised process design, the analysis and assessment of potential risks and close collaboration between the sender and the freight carrier.
